Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of lice infestations
3.2.1.2 Easy availability of lice treatment products
3.2.1.3 Preference for natural and non-toxic products
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of awareness
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Million)
5.1 Key trends
5.2 OTC products
5.2.1 Permethrin
5.2.2 Pyrethrin
5.2.3 Other OTC products
5.3 Prescription medications
5.3.1 Ivermectin
5.3.2 Spinosad
5.3.3 Malathion
5.3.4 Other prescription medications
Chapter 6 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Million)
6.1 Key trends
6.2 Branded
6.3 Generic
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Million)
7.1 Key trends
7.2 Oral
7.3 Topical
Chapter 8 Market Estimates and Forecast, By Condition, 2021 – 2032 ($ Million)
8.1 Key trends
8.2 Pediculosis capitis
8.3 Pediculosis corporis
8.4 Pediculosis pubis
Chapter 9 Market Estimates and Forecast, By Dosage Form, 2021 – 2032 ($ Million)
9.1 Key trends
9.2 Tablets
9.3 Shampoos
9.4 Lotions
9.5 Cream
9.6 Other dosage forms
Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Million)
10.1 Key trends
10.2 Hospital pharmacies
10.3 Retail pharmacies
10.4 Other distribution channels
Chapter 11 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
11.1 Key trends
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Australia
11.4.5 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 Alliance Pharma PLC
12.2 Azurity Pharmaceuticals, Inc.
12.3 Fleming Medical Ltd.
12.4 Oystershell Consumer Health
12.5 Parapro Pharmaceuticals
12.6 Perrigo Company plc
12.7 Prestige Consumer Healthcare Inc.
12.8 Reckitt Benckiser Group plc
12.9 Sanofi S.A.
12.10 Thornton & Ross Ltd.
